当前位置:SCI论文发表网>SCI期刊>Cancers

Cancers

SCI之家头像
创始人 研老师

期刊基本信息

期刊名称:Cancers

期刊ISSN:2072-6694

期刊数据表:

最新中科院JCR分区
大类(学科)
小类(学科)
JCR学科排名
医学
ONCOLOGY(肿瘤学) 2区
45/223
最新的影响因子
6.126
最新公布的期刊年发文量
年度总发文量 年度论文发表量 年度综述发表量
169 41 128
总被引频次 5196
特征因子 0.011780

Cancers英文简介:

Cancers (ISSN 2072-6694; CODEN: CANCCT) is an open access journal of oncology published monthly online by MDPI.Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, unique features of this journal: manuscripts regarding research proposals and research ideas will be particularly welcomed electronic files or software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material we also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds we accept studies showing meaningful but negative results. While there are many journals that focus on cancer studies, none of them actively accepts negative results. As a result, most negative data end up not being in the public domain even if the data were meaningfully negative and the study well designed. By accepting those negative results, our journal encourages scientists to share those data so that they would not need to repeat the experiments that somebody else has already done. Open Access - free for readers, with publishing fees paid by authors or their institutions. Rapid publication: manuscripts are peer-reviewed and a first decision provided to authors approximately 29 days after submission; acceptance to publication is undertaken in 6 days (median values for papers published in this journal in 2016). For Cancers (ISSN 2072-6694), authors are asked to pay a fee of 850 CHF (Swiss Francs) per processed paper, but only if the article is accepted for publication in this journal after peer-review and possible revision of the manuscript. Note that many national and private research funding organizations and universities explicitly cover such fees for articles originated in funded research projects. Discounts are available for authors from institutes that participate with MDPI''s membership program. In addition to Swiss Francs (CHF), we also accept payment of the fees in Euros (EUR), US Dollars (USD) or Chinese Yuan (CNY). Current exchange rates published at XE plus 5% exchange commission apply.

Cancers中文简介:

癌症(ISSN 2072 - 6694;CODEN: CANCCT)是一份开放获取的肿瘤杂志,每月由MDPI在线出版。《癌症》(ISSN 2072-6694)是一本国际性的、同行评审的肿瘤学开放获取期刊。它发表评论、定期研究论文和简短的交流。我们的目标是鼓励科学家尽可能详细地发表他们的实验和理论结果。这篇论文的篇幅没有限制。必须提供完整的实验细节,以便重现结果。此外,这本杂志还有一些独特的特点:特别欢迎有关研究建议和研究想法的手稿有关计算和实验程序的全部细节的电子文件或软件,如不能正常发表,可作为补充材料存放我们也接受与更广泛的读者交流有关公共资金资助的研究项目的手稿我们接受有意义但结果消极的研究。虽然有很多期刊关注癌症研究,但没有一本积极接受负面结果。结果,大多数负面数据最终都不在公共领域,即使这些数据是有意义的负面数据,而且研究设计得很好。通过接受这些消极的结果,我们的杂志鼓励科学家们分享这些数据,这样他们就不需要重复别人已经做过的实验。开放存取-免费为读者,出版费用由作者或他们的机构支付。快速出版:稿件经过同行评审,并在投稿后约29天向作者提供第一个决定;发表验收时间为6天(2016年发表论文中位数)。对于癌症(ISSN 2072-6694),作者被要求为每一篇处理过的论文支付850瑞士法郎(瑞士法郎)的费用,但前提是这篇文章在同行评审和可能的手稿修改后被接受发表在本刊上。请注意,许多国家和私人研究资助机构和大学都明确为源自资助研究项目的文章支付此类费用。参加MDPI会员计划的机构的作者可享受折扣。除瑞士法郎(CHF)外,我们还接受欧元(EUR)、美元(USD)或人民币(CNY)的费用支付。现行汇率按XE + 5%的汇率计算。

Cancers在线问答:

© http://www.scizj.com/sci/12130.html
SCI之家介绍

SCI之家专业从事SCI期刊、SSCI期刊、EI源刊、SCOPUS期刊、论文咨询服务。SCI之家有来自美国、新加坡、马来西亚的专业英文母语化编审指导团队为您提供专业的英文论文母语润色服务。专注国际学术咨询服务,我们是认真的!

投稿咨询

SCOPUS知识>
关注:601+
2024-10-28 16:10:34
关注:723+
2024-04-22 17:04:35
关注:706+
2024-02-19 17:02:15
关注:652+
2024-01-15 17:01:08
关注:364+
2024-01-12 17:01:11
关注:402+
2023-12-28 17:12:03
最新SCI问答 >
关注:687+
2024-11-20 18:11:41
关注:546+
2024-11-18 18:11:35
关注:505+
2024-11-16 15:11:53
热门SCI问答 >
关注:927+
2024-11-18 18:11:32
关注:869+
2024-11-19 18:11:11
关注:762+
2024-11-14 18:11:36
EI期刊百问 >
关注:636+
2024-10-19 16:10:37
关注:475+
2024-09-14 11:09:45
关注:749+
2024-09-10 15:09:57
关注:374+
2024-07-23 15:07:04
关注:552+
2024-07-19 16:07:20
关注:490+
2024-07-17 11:07:46